Skip to main content
Premium Trial:

Request an Annual Quote

NanoDetection Technology, Three Academic Labs to Co-Develop Bird Flu Detector

NEW YORK (GenomeWeb News) - NanoDetection Technology and three academic research centers plan to develop an onsite avian influenza detection system, the company said today. 
 
The partners are the University of Tennessee Health Science Center, St. Jude Children’s Research Hospital, and Oak Ridge National Laboratory. 
 
The technology is based on a biochip that detects photons produced as a result of DNA hybridization or protein conjugation, which constitutes a “positive” result.
 
NanoDetection said the detector is “chemistry and sample agnostic,” meaning that the same biochip “can conduct multiple, simultaneous tests and can use most biological and environmental samples.”
 
NanoDetection Technology CEO Charlie Barnett said the detector’s test results would not require any sophisticated analysis.
 
Additional details were not disclosed.

The Scan

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.

Study Uncovers Genetic Mutation in Childhood Glaucoma

A study in the Journal of Clinical Investigation ties a heterozygous missense variant in thrombospondin 1 to childhood glaucoma.

Gene Co-Expression Database for Humans, Model Organisms Gets Update

GeneFriends has been updated to include gene and transcript co-expression networks based on RNA-seq data from 46,475 human and 34,322 mouse samples, a new paper in Nucleic Acids Research says.

New Study Investigates Genomics of Fanconi Anemia Repair Pathway in Cancer

A Rockefeller University team reports in Nature that FA repair deficiency leads to structural variants that can contribute to genomic instability.